After Six Years FDA Finalizes Guidance on Assessing Abuse Potential of Drugs
After 6 years US FDA finalized Guidance on Assessing Abuse Potential of Drugs on 18th January 2017. The first draft
Read moreAfter 6 years US FDA finalized Guidance on Assessing Abuse Potential of Drugs on 18th January 2017. The first draft
Read moreThe US FDA’s Center for Biologics Evaluation and Research, recently released final guidance for the investigational new drug (IND) submissions
Read more